Novo Nordisk has asked the Food and Drug Administration to bar compounding pharmacies from making copies of its blockbuster weight loss drug semaglutide, arguing that the medication is too complex ...

The OnePlus 13 has now been fully unveiled, and while so far you can only buy it in China, that means we know just about everything about it. Highlights include a gigantic battery, a top-end ...

The OnePlus 13 is finally official, the company announced the flagship at a special event in China on October 31. This phone is the follow-up of the last-gen OnePlus 12, which was released in December ...

OnePlus has launched the OnePlus 13 smartphone in China. The new phone has a Snapdragon 8 Elite chip, IP68/IP69 ratings, and a 6,000mAh battery. The OnePlus 13 starts at ~$632 in its home market ...

The Danish drug company Novo Nordisk has been sanctioned by the UK pharmaceutical industry regulator over the way it has promoted its weight loss medications semaglutide (Ozempic/Wegovy) and ...

The Find X8 and Find X8 Pro are set to receive an international release imminently, Oppo said at its China launch. Sareena is a senior editor for CNET covering the mobile beat including device ...

Get the latest car news, reviews, and features.

Back in 2021, a new brand founded by 2009 Formula 1 champion Jenson Button and celebrity mechanic Ant Anstead revealed plans to build a low-production supercar inspired by the Lotus Type 62.

Patients taking Novo Nordisk A/S’s Ozempic were at significantly reduced risk of being diagnosed with Alzheimer’s, according to new research that adds to the evidence surrounding the drug’s ...

The group of like-named companies that include Novo Holdings and Novo Nordisk—the two tied to a multibillion-dollar buyout of Catalent currently under FTC review—ultimately send proceeds to the Novo ...

Novo Nordisk’s semaglutide has been linked to a 40% to 70% reduction in the risk of Alzheimer’s disease diagnosis in a real-world study of patients with type 2 diabetes published Thursday in Alzheimer ...

Novo Nordisk wants the Food and Drug Administration (FDA) to prevent compounding pharmacies from manufacturing their own versions of the company’s popular weight loss drug Wegovy and diabetes ...